Ratings Genpact Limited Deutsche Boerse AG

Equities

35G

BMG3922B1072

Real-time Estimate Tradegate Other stock markets 01:16:42 2024-06-03 pm EDT			5-day change	1st Jan Change
29.76 ^EUR	+0.35%		-1.48%	-3.13%

May. 31	Genpact Units Price $400 Million Notes Offering	MT
May. 21	Transcript : Genpact Limited Presents at The 52nd J.P. Morgan Annual Global Technology, Media & Communications Conference, May-21-2024 08:50 AM

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Historically, the company has been releasing figures that are above expectations.

Weaknesses

The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Sector: Business Support Services

	1st Jan change	Capi.	ESG Refinitiv
GENPACT LIMITED	-3.13%	5.95B	-
CINTAS CORPORATION	+11.63%	68.79B	B+
JACOBS SOLUTIONS INC.	+5.51%	17.45B	B+
BUREAU VERITAS SA	+21.03%	13.58B	A-
RB GLOBAL, INC.	+5.65%	13.35B	B-
INTERTEK GROUP PLC	+12.72%	9.8B	B-
TELEPERFORMANCE SE	-19.16%	6.74B	C
MAXIMUS, INC.	+1.68%	5.23B	B-
EXLSERVICE HOLDINGS, INC.	-4.28%	4.85B	A-
EXPONENT, INC.	+7.76%	4.82B	C-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes